$115.00
Andarine S4 by Genetix Pharma is a powerful SARM designed to boost strength, enhance muscle definition, and support fat loss. Each bottle includes 50 tablets, with 20mg per tablet, offering targeted results for Canadian men aiming to improve their physique and performance without excess bulk or water retention.
Genetix Pharma’s Andarine S4 is a powerful SARM (Selective Androgen Receptor Modulator) crafted for Canadian men committed to building strength, achieving muscle definition, and reducing fat. Unlike traditional steroids, Andarine S4 delivers these benefits with fewer side effects, making it an excellent choice for athletes and fitness enthusiasts alike.
Andarine S4 is ideal for Canadian men aged 18 to 55 seeking to enhance their strength, muscle definition, and overall fitness. It works exceptionally well for bodybuilders, athletes, and individuals focused on sculpting a leaner, stronger physique.
Whether you’re breaking through training plateaus or cutting fat while maintaining muscle mass, Andarine S4 supports your goals effectively. Its ability to deliver results without hormonal suppression makes it a safer alternative for achieving a toned, athletic body.
Genetix Pharma is renowned for its commitment to quality and performance. Their Andarine S4 is produced to deliver consistent results, offering a reliable solution for men who prioritize safety and effectiveness in their fitness journey.
Every batch undergoes rigorous testing to ensure purity and potency. By choosing Andarine S4, you gain access to a supplement trusted by fitness enthusiasts and athletes across Canada.
Follow the recommended dosage guidelines to achieve the best results while ensuring safety. Customize your intake based on your specific fitness goals and cycles.
Only logged in customers who have purchased this product may leave a review.
$110.00 Original price was: $110.00.$90.00Current price is: $90.00.
$120.00 Original price was: $120.00.$90.00Current price is: $90.00.
SteroidsCanada.ca 2025
$115.00
Reviews
There are no reviews yet.